anti-BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14) Anticorps

The protein encoded by BCL2L14 belongs to the BCL2 protein family. De plus, nous expédions BCL2-Like 14 (Apoptosis Facilitator) Protéines (7) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
BCL2L14 79370 Q9BZR8
BCL2L14 66813 Q9CPT0
BCL2L14 500348 Q6AYK4
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-BCL2-Like 14 (Apoptosis Facilitator) Anticorps sur anticorps-enligne.fr

Showing 10 out of 69 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Lapin Inconjugué IHC, ELISA, WB   100 μg 15 to 19 Days
$513.04
Détails
Humain Lapin Inconjugué IC, IF, WB Immunofluorescent analysis of BCLG staining in Hela cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody i Western blot analysis of BCLG expression in mouse liver (A), rat brain (B) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Détails
Humain Lapin Inconjugué ELISA, IHC, WB Western blot analysis of BCL2L14 using A549 whole cell lysates ABIN6279134 at 1/100 staining Mouse testis tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22¡ãC. An HRP conjugated goat anti-rabbit antibody was used as the secondary 100 μL 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué EIA, IHC (p), WB   0.1 mg 4 to 8 Days
$539.00
Détails
Humain Lapin Inconjugué EIA, IHC (p), WB 0.4 mL 11 to 13 Days
$792.00
Détails
Humain Lapin Inconjugué IF (p), IHC (p) Formalin-fixed and paraffin embedded mouse lung labeled with Rabbit Anti Bcl G/BCL2 like 14 Polyclonal Antibody, Unconjugated (ABIN872737) at 1:200 followed by conjugation to the secondary antibody and DAB staining 100 μL 3 to 7 Days
$327.80
Détails
Humain Lapin Inconjugué ELISA, FM, IHC, WB Immunofluorescence of Bcl-G Antibody Immunofluorescence Microscopy of Bcl-G antibody. Cell Type: mouse testis cells. Fixation: 0.5% PFA. Antigen retrieval: not required. Primary antibody: Bcl-G antibody at 10 µg/mL for 1 h at RT. Secondary antibody: Fluorescein rabbit secondary antibody at 1:10,000 for 45 min at RT. Localization: Bcl-G is cytoplasmic. Staining: Bcl-G as red fluorescent signal. 100 μg 1 to 2 Days
$405.90
Détails
Humain Souris Inconjugué IP, ELISA, WB Western Blot analysis of BCL2L14 expression in transfected 293T cell line by BCL2L14 monoclonal antibody (M02), clone 1D11.Lane 1: BCL2L14 transfected lysate(36.6 KDa).Lane 2: Non-transfected lysate. Immunoprecipitation of BCL2L14 transfected lysate using anti-BCL2L14 monoclonal antibody and Protein A Magnetic Bead , and immunoblotted with BCL2L14 MaxPab rabbit polyclonal antibody. 100 μg 11 to 12 Days
$440.00
Détails
Humain Lapin Inconjugué IF, WB WesternBlot (WB) analysis of BCL2L14 polyclonal antibody 100 μL 6 to 11 Days
$390.55
Détails
Humain Souris Inconjugué WB Western Blot analysis of BCL2L14 expression in transfected 293T cell line by BCL2L14 MaxPab polyclonal antibody.Lane 1: BCL2L14 transfected lysate(35.97 KDa).Lane 2: Non-transfected lysate. 50 μL 11 to 12 Days
$440.00
Détails

anti-BCL2-Like 14 (Apoptosis Facilitator) Anticorps mieux référencés

  1. Human Polyclonal BCL2L14 Primary Antibody pour IHC (p), WB - ABIN541212 : Guo, Godzik, Reed: Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. dans The Journal of biological chemistry 2001 (PubMed)
    Show all 3 Pubmed References

  2. Human Polyclonal BCL2L14 Primary Antibody pour IHC, ELISA - ABIN1001875 : Cory, Huang, Adams: The Bcl-2 family: roles in cell survival and oncogenesis. dans Oncogene 2003 (PubMed)
    Show all 3 Pubmed References

Plus d’anticorps contre BCL2-Like 14 (Apoptosis Facilitator) partenaires d’interaction

Human BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14) interaction partners

  1. BCL2L14 knockdown exhibited similar effects similar to those of miR-496 overexpression, and the restored BCL2L14expression reversed the protective effects of miR-496 on SH-SY5Y cells

  2. The results show that BCLG is overexpressed more frequently in medullary breast carcinoma than other histological types of basal like carcinomas.

  3. Data indicate that LRP6, BCL2L14, DUSP16, CREBL2, and CDKN1B were involed in centromeric (12p11.21-12p13.2) deletion in ETV6-RUNX1 B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

  4. Single nucleotide polymorphism in BCL2L14 is associated with lung cancer.

  5. prior knockdown of Bcl-G expression ablates the stimulation of basal apoptosis by FAU, consistent with an essential downstream role for Bcl-G, itself a candidate tumour suppressor, in mediating the apoptosis regulatory role of FAU.

  6. siRNA downregulation of Bcl-G inhibited breast cancer cell apoptosis. Adding an siRNA against Fau revealed control of Bcl-G by Fau. The most important factors controlling Bcl-G are post-translational modification by Fau & MELK, not transcription rate.

  7. There was no somatic mutation of BH3 domains of Bad, Bmf and Bcl-G genes in transitional cell carcinoma samples. The data presented here indicate that BH3 domain mutation of these genes is rare in TCCs and may not contribute to the pathogenesis of TCCs.

  8. the kinase activity of MELK is likely to affect mammary carcinogenesis through inhibition of the pro-apoptotic function of Bcl-GL

  9. data presented here indicate that BH3 domain mutation of the proapoptotic genes Bad, Bmf and Bcl-G is rare in laryngeal squamous cell carcinoma and may not contribute to the apoptosis-resistance mechanisms of laryngeal squamous cell carcinoma

  10. JAB1 is involved in the regulation of mitochondrial apoptotic pathway through specific interaction with BclGs.

  11. Increased BclG(L) expression may contribute to the aberrant CD4+ T cell apoptosis which causes an inappropriate immune response and impaired homeostasis in systemic lupus erythematosus.

Mouse (Murine) BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14) interaction partners

  1. CD3/CD28-inducible MNSFbeta-Bcl-G complex may be involved in the regulation of T cell function and survival.

  2. The Bcl-G interacts specifically with proteins of the transport particle protein complex.

  3. Bcl-G is expressed highly in mature spermatids in the testis, CD8(+) conventional dendritic cells (DCs) in hematopoietic tissues and diverse epithelial cell types, including those lining the gastrointestinal and respiratory tracts.

BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14) profil antigène

Profil protéine

The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. Overexpression of this gene has been shown to induce apoptosis in cells. Three alternatively spliced transcript variants encoding two distinct isoforms have been reported for this gene.

Gene names and symbols associated with BCL2L14

  • BCL2 like 14 (BCL2L14) anticorps
  • BCL2-like 14 (apoptosis facilitator) (Bcl2l14) anticorps
  • BCL2 like 14 (Bcl2l14) anticorps
  • 4930452K23Rik anticorps
  • 4933405K19Rik anticorps
  • 9030625M01Rik anticorps
  • AI429211 anticorps
  • Bclg anticorps

Protein level used designations for BCL2L14

apoptosis facilitator Bcl-2-like protein 14 , apoptosis regulator BCL-G , bcl2-L-14

GENE ID SPECIES
79370 Homo sapiens
66813 Mus musculus
500348 Rattus norvegicus
508365 Bos taurus
Fournisseurs de qualité sélectionnés pour anti-BCL2-Like 14 (Apoptosis Facilitator) (BCL2L14) Anticorps
Avez-vous cherché autre chose?